TY - JOUR
T1 - Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations
T2 - findings from the Rural Opioid Initiative
AU - Rudolph, Abby E.
AU - Nance, Robin M.
AU - Bobashev, Georgiy
AU - Brook, Daniel
AU - Akhtar, Wajiha
AU - Cook, Ryan
AU - Cooper, Hannah L.
AU - Friedmann, Peter D.
AU - Frost, Simon D.W.
AU - Go, Vivian F.
AU - Jenkins, Wiley D.
AU - Korthuis, Philip T.
AU - Miller, William C.
AU - Pho, Mai T.
AU - Ruderman, Stephanie A.
AU - Seal, David W.
AU - Stopka, Thomas J.
AU - Westergaard, Ryan P.
AU - Young, April M.
AU - Zule, William A.
AU - Tsui, Judith I.
AU - Crane, Heidi M.
AU - Whitney, Bridget M.
AU - Delaney, Joseph A.C.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Background: Accurate prevalence estimates of drug use and its harms are important to characterize burden and develop interventions to reduce negative health outcomes and disparities. Lack of a sampling frame for marginalized/stigmatized populations, including persons who use drugs (PWUD) in rural settings, makes this challenging. Respondent-driven sampling (RDS) is frequently used to recruit PWUD. However, the validity of RDS-generated population-level prevalence estimates relies on assumptions that should be evaluated. Methods: RDS was used to recruit PWUD across seven Rural Opioid Initiative studies between 2018-2020. To evaluate RDS assumptions, we computed recruitment homophily and design effects, generated convergence and bottleneck plots, and tested for recruitment and degree differences. We compared sample proportions with three RDS-adjusted estimators (two variations of RDS-I and RDS-II) for five variables of interest (past 30-day use of heroin, fentanyl, and methamphetamine; past 6-month homelessness; and being positive for hepatitis C virus (HCV) antibody) using linear regression with robust confidence intervals. We compared regression estimates for the associations between HCV positive antibody status and (a) heroin use, (b) fentanyl use, and (c) age using RDS-1 and RDS-II probability weights and no weights using logistic and modified Poisson regression and random-effects meta-analyses. Results: Among 2,842 PWUD, median age was 34 years and 43% were female. Most participants (54%) reported opioids as their drug of choice, however regional differences were present (e.g., methamphetamine range: 4-52%). Many recruitment chains were not long enough to achieve sample equilibrium. Recruitment homophily was present for some variables. Differences with respect to recruitment and degree varied across studies. Prevalence estimates varied only slightly with different RDS weighting approaches, most confidence intervals overlapped. Variations in measures of association varied little based on weighting approach. Conclusions: RDS was a useful recruitment tool for PWUD in rural settings. However, several violations of key RDS assumptions were observed which slightly impacts estimation of proportion although not associations.
AB - Background: Accurate prevalence estimates of drug use and its harms are important to characterize burden and develop interventions to reduce negative health outcomes and disparities. Lack of a sampling frame for marginalized/stigmatized populations, including persons who use drugs (PWUD) in rural settings, makes this challenging. Respondent-driven sampling (RDS) is frequently used to recruit PWUD. However, the validity of RDS-generated population-level prevalence estimates relies on assumptions that should be evaluated. Methods: RDS was used to recruit PWUD across seven Rural Opioid Initiative studies between 2018-2020. To evaluate RDS assumptions, we computed recruitment homophily and design effects, generated convergence and bottleneck plots, and tested for recruitment and degree differences. We compared sample proportions with three RDS-adjusted estimators (two variations of RDS-I and RDS-II) for five variables of interest (past 30-day use of heroin, fentanyl, and methamphetamine; past 6-month homelessness; and being positive for hepatitis C virus (HCV) antibody) using linear regression with robust confidence intervals. We compared regression estimates for the associations between HCV positive antibody status and (a) heroin use, (b) fentanyl use, and (c) age using RDS-1 and RDS-II probability weights and no weights using logistic and modified Poisson regression and random-effects meta-analyses. Results: Among 2,842 PWUD, median age was 34 years and 43% were female. Most participants (54%) reported opioids as their drug of choice, however regional differences were present (e.g., methamphetamine range: 4-52%). Many recruitment chains were not long enough to achieve sample equilibrium. Recruitment homophily was present for some variables. Differences with respect to recruitment and degree varied across studies. Prevalence estimates varied only slightly with different RDS weighting approaches, most confidence intervals overlapped. Variations in measures of association varied little based on weighting approach. Conclusions: RDS was a useful recruitment tool for PWUD in rural settings. However, several violations of key RDS assumptions were observed which slightly impacts estimation of proportion although not associations.
KW - Drug use
KW - Methamphetamine
KW - Opioids
KW - Respondent-driven sampling
KW - Rural health
UR - http://www.scopus.com/inward/record.url?scp=85191046450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191046450&partnerID=8YFLogxK
U2 - 10.1186/s12874-024-02206-5
DO - 10.1186/s12874-024-02206-5
M3 - Article
C2 - 38654219
AN - SCOPUS:85191046450
SN - 1471-2288
VL - 24
JO - BMC Medical Research Methodology
JF - BMC Medical Research Methodology
IS - 1
M1 - 94
ER -